Prognosis of presyncope in patients with structural heart disease;Pronóstico del presíncope en pacientes con cardiopatía estructural

Revista Espanola de Cardiologia

Volumn 57, Issue 7, 2004, Pages 629-634

  García Reverte, Juan ^a   Llamas Lázaro, Cristina ^b   García Alberola, Arcadi ^b,e   Gómez Zapata, Maximiliano ^c   García García, Rafael ^d   Sánchez Muñoz, Juan J ^b   Martínez Sánchez, Juan ^b   Valdéz Chávarri, Mariano ^b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

^d Instituto Anatómico Forense   (Spain)

^e NONE   (Spain)

Author keywords

Heart disease; Presyncope; Prognosis; Syncope

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL FEATURE; DEMOGRAPHY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; INTERVIEW; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL SOCIETY; PROGNOSIS; RELATIVE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STRATIFICATION; SUDDEN DEATH; SURVIVAL; SYNCOPE;

EID: 4344565302     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13064188     Document Type: Article

References (24)

1. Olshansky B. Syncope: overview and approach to management. En: Grubb BP, Olshansky B, editors. Syncope: mechanism and management. Armonk: Futura, 1998; p. 15-71.
2. Kapoor WN. Current evaluation and management of syncope. Circulation 2002;106:1606-9.
3. Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001;22:1256-306.
4. Sloane PD, Coeytaux RR, Beck RS, Dallara J. Dizziness: state of the science. Ann Intern Med 2001;134(Suppl):823-32.
5. Brilakis ES, Shen WK, Hammill SC, Hodge DO, Rea RF, Lexvold NY, et al. Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. PACE 2001;24:1623-30.
6. Brignole M, Menozzi C, Moya A, García-Civera R, Mont L, Álvarez M, et al. International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 2001;104:1045-50.
7. Menozzi C, Brignole M, García-Civera R, Moya A, Botto G, Tercedor L, et al. International Study on Syncope of Uncertain Etiology (ISSUE) Investigators. Mechanism of syncope in patients with heart disease and negative electrophysiologic test. Circulation 2002;105:2741-5.
8. Maisel WH, Stevenson WG. Syncope. Getting to the heart of the matter. N Engl J Med 2002;347:931-3.
9. Kroenke K, Price RK. Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993;153:2474-80.
10. Boult C, Murphy J, Sloane P, Mor V, Drone C. The relation of dizziness to functional decline. J Am Geriatr Soc 1991;39:858-61.
11. Bailey KE, Sloane PD, Mitchell M, Preisser J. Which primary care patients with dizziness will develop persistent impairment? Arch Fam Med 1993;2:847-52.
12. Link MS, Kim KS, Homoud MK, Estes MN, Wang PJ. Long-term outcome of patients with syncope associated with coronary artery disease and a nondiagnostic electrophysiologic evaluation. Am J Cardiol 1999;83:1334-7.
13. Nierop P, Van Mechelen R, Van Elsäcker A, Luitjen RH, Elhendy A. Heart rhythm during syncope and presyncope: results of implantable loop recorders. PACE 2000;23:1532-8.
14. Krahn AD, Klein GJ, Yee R, Skanes AC, for the Reveal Investigators. Predictive value of presyncope in patients monitored for assessment of syncope. Am Heart J 2001;141:817-21.
15. Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C, for the Reveal Investigators. Use of an extended monitoring strategy in patients with problematic syncope. Circulation 1999;99:406-10.
16. Kapoor WN, Hanusa B. Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med 1996;100:646-55.
17. Middlekauff H, Stevenson WG, Stevenson LW, Saxon LA. Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. J Am Coll Cardiol 1993;21:110-6.
18. Link MS, Costeas XF, Griffith JL, Colbum CD, Estes NA 3rd, Wang PJ. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular tachycardia. J Am Coll Cardiol 1997;29:370-5.
19. Militianu A, Salacata A, Seibert K, Kehoe R, Baga JJ, Meissner MD, et al. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or nearsyncope. J Cardiovasc Electrophysiol 1997;8: 1087-97.
20. Pires LA, May LM, Ravi S, Parry JT, Lal VR, Nino CL. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillator. Am J Cardiol 2000;85:725-8.
21. Fonarow GC, Feliciano Z, Boyle NG, Knight L, Woo MA, Moriguchi JD, et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol 2000;85:981-5.
22. Linzer M, Yang EH, Estes NAM, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 1: value of history, physical examination, and electrocardiography. Ann Intern Med 1997;126: 989-96.
23. Linzer M, Yang EH, Estes NAM, Wang P, Vorperian VR, Kapoor WN. Diagnosing syncope. Part 2: unexplained syncope. Ann Intern Med 1997;127:76-86.
24. Moazez F, Peter T, Simonson J, Mandel WJ, Vaughn C, Gang E. Syncope of unknown origin: clinical, noninvasive, and electrophysiologic determinants of arrhythmia induction and symptom recurrence during long-term follow-up. Am Heart J 1991; 121:81-8.